These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4933030)

  • 1. Identification of Pseudomonas pseudomallei.
    Zierdt CH; Marsh HH
    Am J Clin Pathol; 1971 May; 55(5):596-603. PubMed ID: 4933030
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas fluorescens biotype G, the dominant fluorescent pseudomonad in South Australian soils and wheat rhizospheres.
    Sands DC; Rovira AD
    J Appl Bacteriol; 1971 Mar; 34(1):261-75. PubMed ID: 4935441
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical microbiology of unusual Pseudomonas species.
    von Graevenitz A
    Prog Clin Pathol; 1973; 5():185-218. PubMed ID: 4205734
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriocins of the phytopathogens Pseudomonas syringae, P. glycinea, and P. phaseolicola.
    Vidaver AK; Mathys ML; Thomas ME; Schuster ML
    Can J Microbiol; 1972 Jun; 18(6):705-13. PubMed ID: 4556096
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possible use of the indirect hemagglutination reaction for determining the sensitivity of the bacteria of glanders and melioidosis to antibiotics].
    Ferster LN; Zharkova VA; Khrapova NP; Volkov EA
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):454-6. PubMed ID: 3740827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and rapid identification of Pseudomonas pseudomallei from other gram-negative bacteria.
    Farkas-Himsley H
    Am J Clin Pathol; 1968 Jun; 49(6):850-6. PubMed ID: 4871604
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of Pseudomonas haemolysin.
    Výmola F; Lochmann O
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(3):302-9. PubMed ID: 4213604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of the antigenic profiles common between Pseudomonas phaseolicola (Burk) Dowson and Pseudomonas syringae Van Hall for the ytping of the last species].
    Coleno A
    C R Acad Hebd Seances Acad Sci D; 1968 Jun; 266(26):2516-8. PubMed ID: 4971306
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.
    Dance DA; Wuthiekanun V; Naigowit P; White NJ
    J Clin Pathol; 1989 Jun; 42(6):645-8. PubMed ID: 2472432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structure of the causative agent of melioidsis and its cellular structures].
    Efimtseva EP; Shtesser LG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):29-32. PubMed ID: 4212546
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of Ps. pycoyanea strains isolated from pathological material.
    Kumari S; Bhatia SL; Agarwal DS
    Indian J Med Res; 1974 Apr; 62(4):484-90. PubMed ID: 4435859
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions in vitro between agents used to treat melioidosis.
    Dance DA; Wuthiekanun V; Chaowagul W; White NJ
    J Antimicrob Chemother; 1989 Sep; 24(3):311-6. PubMed ID: 2681117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological properties of the causative agent of pseudotuberculosis isolated from scarlatina-like fever patients].
    Gurleva GG; Domaradskiĭ IV; Smolikova LM; Khaliapina EE; Grigor'ian EG
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Sep; 50(9):125-9. PubMed ID: 4597196
    [No Abstract]   [Full Text] [Related]  

  • 14. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.
    Dance DA; Wuthiekanun V; Chaowagul W; White NJ
    J Antimicrob Chemother; 1989 Sep; 24(3):295-309. PubMed ID: 2681116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid techniques for the identification of anaerobic bacteria and presumptive diagnosis.
    Tabaqchali S
    Scand J Infect Dis Suppl; 1982; 35():23-30. PubMed ID: 6188205
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluorescent pseudomonads. Their antibiotic sensitivity, clinical significance and problems of identification].
    Shenderov BA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):225-34. PubMed ID: 3087273
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of Pseudomonas species isolated from clinical specimens.
    Gilardi GL
    Appl Microbiol; 1971 Mar; 21(3):414-9. PubMed ID: 4928600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach combining the Calgary Biofilm Device and Phenotype MicroArray for the characterization of the chemical sensitivity of bacterial biofilms.
    Santopolo L; Marchi E; Frediani L; Decorosi F; Viti C; Giovannetti L
    Biofouling; 2012; 28(9):1023-32. PubMed ID: 23004019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice.
    Wuthiekanun V; Dance DA; Wattanagoon Y; Supputtamongkol Y; Chaowagul W; White NJ
    J Med Microbiol; 1990 Oct; 33(2):121-6. PubMed ID: 2231678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors.
    Gillespie SH; McEniry DW; Felmingham D
    J Antimicrob Chemother; 1987 Oct; 20(4):612-4. PubMed ID: 2824429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.